ライフサイエンスコーパス: biotech

1 d on a report from the manufacturer (Krystal Biotech).

2 Idorsia Pharmaceuticals and Janssen Biotech.

3 Janssen Research & Development and Legend Biotech.

4 Oliver et al., Trends Biotech.

5 Robert Wood Johnson Foundation, and Janssen Biotech.

6 h Care, Chugai, Pharmion, Celgene, and Ortho Biotech.

7 randomisation scheme was generated by Facet Biotech.

8 h Care, Chugai, Pharmion, Celgene, and Ortho Biotech.

9 ent will KSR limit combination inventions in biotech?

10 Carlsbad, CA) and BeeBlot/ViraScan (Viramed Biotech AG, Munich, Germany), using 518 serum specimens

11 iotech], and Treponema ViraBlot IgG [Viramed Biotech AG, Planegg, Germany]) using serum samples (n =

12 nzyme was measured using two separate ScheBo-Biotech-AG ELISA kits for stool and plasma samples.

13 r therapeutics, why academic researchers and biotech and pharmaceutical companies are so excited, and

14 ic exploration of methods for distinguishing biotech and pharmaceutical companies yields a dynamic, m

15 new molecular targets for the development of biotech and pharmaceutical products.

16 TP) rights in agricultural biotechnology (ag-biotech) and transgenic plants has become critically imp

17 tory agency representatives; pharmaceutical, biotech, and food industry leaders; patent attorneys; ec

18 EIA [Phoenix Biotech], Trep-ID EIA [Phoenix Biotech], and Treponema ViraBlot IgG [Viramed Biotech AG

19 iated with C-MEMS and C-NEMS devices used in biotech applications are presented.

20 ied as promising technologies for a range of biotech applications, including electrochemical biosenso

21 ea but also for improving the development of biotech applications.

22 ld the potential for both basic research and biotech applications.

23 as a potential surrogate for PHHs in various biotech applications.

24 y levitating a diamond enabled a redesign of biotech automation.

25 sess the effectiveness of CoronaVac (Sinovac Biotech), AZD1222 (Oxford-AstraZeneca), or BNT162b2 (Pfi

26 There is an increasing demand for biotech-based production of recombinant proteins for use

27 ked to treatment with the exception of Facet Biotech bioanalysts who prepared data for the data safet

28 herapeutics, Avid Radiopharmaceuticals, Bial Biotech, Biohaven, Biogen, BioLegend, Bristol-Myers Squi

29 We assessed performance of the Gotham BioTech Blastomyces antigen (GBA) enzyme immunoassay (EI

30 res, especially in the context of a maturing biotech business 'ecosystem'.

31 the multicenter trial of SYNSORB Pk (SYNSORB Biotech, Calgary, Alberta, Canada) treatment for D+HUS.

32 ealth Care, Chugai, Pharmion, Celgene, Ortho Biotech, Cancer Research UK, Celgene, Merck Sharp & Dohm

33 tested with the Abbott Determine and Trinity Biotech Capillus SR tests in parallel.

34 erpretive systems, TrinBlot/BLOTrix (Trinity Biotech, Carlsbad, CA) and BeeBlot/ViraScan (Viramed Bio

35 tibody assay (DFA) for RSV (Bartels; Trinity Biotech, Carlsbad, CA), and two DFAs for hMPV manufactur

36 The biotech chitosans differ from technical chitosans both i

37 h and early development (R&D) is executed in biotech companies and large pharmaceutical organizations

38 tlier companies, and confirm that nearly all biotech companies are loss-making enterprises, exhibitin

39 In response, a plethora of small biotech companies have emerged with an interest in antib

40 Pharmaceutical and biotech companies have leveraged the incentivized benefi

41 An analysis of 105 mergers among small UK biotech companies over a 10-year period shows that the i

42 bed in vitro in 1961, has become a focus for biotech companies that target it to ameliorate a variety

43 next generation of microbiologists, launched biotech companies to develop new antifungal drugs, serve

44 A consortium of biotech companies, together with the Massachusetts Insti

45 tance of patenting by small and medium-sized biotech companies.

46 bodies in clinical trials are owned by small biotech companies.

47 functions can jeopardize the trust between a biotech company and it stakeholders.

48 hnique has been exploited by Cambridge-based biotech company Biotica Technology Ltd, and their collab

49 A biotech company funded via a pooled investment vehicle c

50 al of 30 ug HEV-239 (Hecolin, Xiamen Innovax Biotech Company Limited, China) administered intramuscul

51 e (IDRI), which operates as a not-for-profit biotech company, may start to pay off during the H1N1 's

52 (OTC), one from Cambridge Biotech Corp.

53 were manufactured by Alexon, Inc., Cambridge Biotech Corp., Meridian, Inc., and Trend Scientific, Inc

54 e significant contributions to production of biotech crops for food, feed, valuable recombinant prote

55 Expensive regulation of biotech crops is prohibitive for local solutions.

56 tory assessment for metabolically engineered biotech crops.

57 So this leaves one with the question of 'can biotech deliver the new antibiotics?'.

58 Widespread adaptation of biotech-derived products of agriculture should lay the f

59 fornia's strategic advantages, including its biotech ecosystem and access to venture capital, numerou

60 d resource usage of these biosensors enables biotech engineers to gain immediate control over precise

61 A young biotech firm can grow in several ways.

62 e, experts from a large pharma company and a biotech firm provide their perspectives.

63 Private biotech firms are awash with funding, raising record-bre

64 emia and large pharmaceutical companies, the biotech firms have been effective instruments of technol

65 ttle is known about the multitude of private biotech firms.

66 ott HIV-1) and Western blot assay (Cambridge-Biotech) for HIV-1 antibody.

67 adjuvant sbVTP (WST11; Tookad Soluble, Steba Biotech, France).

68 the WONDFO SARS-CoV-2 Antibody Test (Wondfo Biotech, Guangzhou, China), using two drops of blood fro

69 Test MCR-1 lateral flow immunoassay (LFA; NG Biotech, Guipry, France) and (ii) the EDTA-colistin brot

70 olates were evaluated by NG-Test Carba 5 (NG Biotech, Guipry, France), the Xpert Carba-R assay (Cephe

71 tal and Chairs the Board of Directors for BB Biotech Healthcare Trust and Xerion Healthcare.

72 on campaign was done with Typbar-TCV (Bharat Biotech, Hyderabad, India) between Feb 25 and March 4, 2

73 n with either one dose of CoronaVac (Sinovac Biotech; inactivated vaccine) or BNT162b2 (Fosun Pharma-

74 201 (Enzo Life Sciences), and SKR038 (GenWay Biotech Inc San Diego USA) immunoassays, as well as spik

75 ert support with no sugar attached) (Synsorb Biotech Inc.) was measured.

76 o explore the ability of Synsorb 90 (Synsorb Biotech Inc., Calgary, Alberta, Canada), and inert suppo

77 s of escalating doses of Marimastat (British Biotech, Inc, Oxford, United Kingdom) in patients with a

78 at (BB-94 and BB-2516, respectively, British Biotech, Inc.); CT1418 (Celltech Therapeutics); CGS27023

79 clinical trials include SYNSORB Pk (SYNSORB Biotech, Inc., Calgary, Alberta, Canada), a drug designe

80 s treated with infliximab (Remicade; Janssen Biotech, Inc., Titusville, NJ) were identified through a

81 ofessional societies, the pharmaceutical and biotech industries, and patient advocacy groups were gat

82 matter of semantics-the core identity of the biotech industry and its products is at stake.

83 impact on crop production, development of a biotech industry and the bio-based economy worldwide.

84 The biotech industry is establishing itself as the discovery

85 ollaborative research may end up costing the biotech industry more and inhibiting innovation.

86 emic institutions play a central role in the biotech industry through technology licensing and the cr

87 Engineering robust microbes for the biotech industry typically requires high-level, genetica

88 ncreasing investment in rare diseases by the biotech industry underscores the importance of genetic e

89 ods for carbohydrate characterization in the biotech industry were compared.

90 enzymes (CAZymes) are very important to the biotech industry, particularly the emerging biofuel indu

91 on is of great interest for research and the biotech industry.

92 revolutionizing biomedicine studies and the biotech industry.

93 mbinant protein titer is a major goal of the biotech industry.

94 is one of the greatest challenges facing the biotech industry.

95 It is now a seller's market in the biotech industry.

96 cross-sector collaboration between academia, biotech, industry, and health care systems will be criti

97 Bharat Biotech International and Indian Council of Medical Rese

98 titutes of Health, Bethesda, USA; and Bharat Biotech International, Hyderabad, India.

99 ive a single dose of TCV (Typbar TCV, Bharat Biotech International, India) or capsular group A mening

100 oassay (EIA), the CAPTIA Syphilis-G (Trinity Biotech, Jamestown, N.Y.), has become available as a dia

101 al to investigate the effect of ATLG (Neovii Biotech, Lexington, MA) on cGVHD-free survival.

102 , Trep-Sure enzyme immunoassay [EIA; Phoenix Biotech, Oakville, Ontario, Canada], Trep-Chek EIA [Phoe

103 mber of new drugs have their origin in small biotech or academia.

104 Many of the antibiotic biotech organizations that were most likely to undertake

105 croalgae, biotech yeast, and, in the future, biotech plant oils).

106 validated the Capillus HIV-1/HIV-2 (Trinity Biotech PLC, Bray, County Wicklow, Ireland) and Determin

107 ry as gold standard (using kits from Trinity Biotech PLC, Wicklow, Ireland) were included.

108 nce of analyte-specific reagents from Gotham Biotech (Portland, ME) for quantitative detection of Bla

109 of using these engineered strains in common biotech processes.

110 ntify these rights, a transgenic plant or ag-biotech product must be dissected into its essential com

111 issues of releasing a transgenic plant or ag-biotech product; rather, it is a management tool for ass

112 Transgenic plants and ag-biotech products embody numerous components and processe

113 production of SLM for biopharmaceutical and biotech protocols.

114 ibine (2-chlorodeoxyadenosine [2-CdA]; Ortho Biotech, Raritan, NJ) is a newer purine analog with pote

115 g increased adoption of (13)C MFA within the biotech research community.

116 With the belief that biotech researchers deserve powerful analysis engines to

117 The existence of a medicinal 'biotech revolution' has been widely accepted and promote

118 Can biotech's cash cushion soften the blow as public markets

119 After a decade of significant challenges, biotech's long-term sustainability depends on making fun

120 formance characteristics of the Accula (Mesa Biotech) SARS-CoV-2 POC test need to be evaluated to inf

121 We find that the performance of the biotech sector is highly sensitive to the presence of a

122 The biotech sector must not only maintain an emphasis on gro

123 China sets its sights on joining the global biotech sector.

124 financial performance of the privately held biotech sector.

125 ioning, these results suggest that future Ag-Biotech Solutions to Striga infestations will need to ca

126 Few things are misunderstood more by biotech startup management teams than the importance of

127 tor of 10x Genomics, an advisor for multiple biotech startups, and now a part-time Vice President, Tr

128 When transferring transgenic plants or ag-biotech to developing nations, scientists from industria

129 new entity, the Pediatric Advanced Medicines Biotech, to lead late-stage development and commercializ

130 le, Ontario, Canada], Trep-Chek EIA [Phoenix Biotech], Trep-ID EIA [Phoenix Biotech], and Treponema V

131 RealArt Parvovirus B19 LC PCR reagent (artus biotech USA, San Francisco, Calif.) for real-time PCR de

132 Janssen Research & Development and Legend Biotech USA.

133 Janssen Research & Development, Legend Biotech USA.

134 ebbing sits on SABs for Celltrion, Singapore Biotech, Vor Biopharma, TLC Biopharmaceuticals and Benev

135 obesity drugs, a chemical library from Vivia Biotech was screened using ExviTech platform.

136 investment that aligns plant and industrial biotech will pay dividends for sustainable energy and ma

137 ation about the publicly traded elite of the biotech world, little is known about the multitude of pr

138 The Pediatric Advanced Medicines Biotech would partner with the academic ecosystem, manuf

139 derived from nonanimal sources (microalgae, biotech yeast, and, in the future, biotech plant oils).